ondansetron has been researched along with Glenoid Labral Tears in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, CH | 1 |
| Song, KS | 1 |
| Min, BW | 1 |
| Lee, KJ | 1 |
| Ha, E | 1 |
| Lee, YC | 1 |
| Lee, YK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of a Multimodal Pain Regimen on Pain Control, Patient Satisfaction and Narcotic Use in Orthopaedic Trauma Patients[NCT02160301] | Phase 4 | 0 participants (Actual) | Interventional | 2017-11-30 | Withdrawn (stopped due to Insufficient infrastructure/funding for enrollment) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for ondansetron and Glenoid Labral Tears
| Article | Year |
|---|---|
Multimodal approach to postoperative pain control in patients undergoing rotator cuff repair.
Topics: Acetaminophen; Adult; Aged; Analgesia, Patient-Controlled; Analgesics; Arthroscopy; Cyclooxygenase 2 | 2011 |